The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...
Morning Overview on MSN
FDA clears 1st dual-action eye drop to fight age-related vision loss
Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
“The last thing a presbyopic patient wants is to abandon their reading glasses and walk around with cosmetically red eyes,” ...
A new treatment vertical in eye care, pharmacologic agents for refractive correction, is in the early stage of ...
The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
January 20, 2026 - PRESSADVANTAGE - ilumin has released a new resource titled Best Cataract Surgeon in Omaha: 14 ...
Barbara Tuszynski was concerned about her vision but confident in her insurance coverage when she went to an eye clinic last ...
Dealbreaker on MSN
Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...
ALEXANDRIA, MN - January 24, 2026 - PRESSADVANTAGE - Individuals living with or at risk for glaucoma in the region can ...
CEDAR RAPIDS, IA - January 27, 2026 - PRESSADVANTAGE - As cases of glaucoma continue to rise across the United States, ...
Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results